HCA Healthcare, Inc. $HCA Stock Holdings Lowered by Pzena Investment Management LLC

Pzena Investment Management LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 99,982 shares of the company’s stock after selling 14,169 shares during the period. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $38,303,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD grew its position in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares during the period. Nuveen LLC acquired a new stake in HCA Healthcare in the first quarter worth about $569,217,000. Pacer Advisors Inc. lifted its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in HCA Healthcare by 0.8% in the first quarter. Principal Financial Group Inc. now owns 880,663 shares of the company’s stock worth $304,313,000 after purchasing an additional 6,888 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 7th. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. Finally, Wells Fargo & Company upped their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $422.31.

HCA Healthcare Price Performance

Shares of HCA opened at $414.73 on Monday. The company has a market capitalization of $97.04 billion, a price-to-earnings ratio of 17.43, a P/E/G ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The business’s 50-day moving average is $405.12 and its 200-day moving average is $376.08.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.